Preclinical progression of new organic compounds with targeted biological activity (Q19981): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The objective of the project is to optimise and preclinical profiling of selected compounds with unique biological activity with the potential to exhibit therapeutic efficacy in minimal side effects in oncology and cardiology. The project will include, inter alia, the preparation of a broad diet of compounds and a thorough testing of biological and particularly pharmacological properties, including in vivo studies. The resulting intellectual pro...) |
(Removed claims) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 92,429,398.87 Czech koruna / rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 3,697,175.9548000004 Euro / rank | |||||||||||||||
| Property / EU contribution: 3,697,175.9548000004 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 3,697,175.9548000004 Euro / qualifier | |||||||||||||||
| |||||||||||||||
Revision as of 16:58, 3 March 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical progression of new organic compounds with targeted biological activity |
Project in Czech Republic financed by DG Regio |
Statements
108,740,469.26 Czech koruna
0 references
84.9999999990804 percent
0 references
1 August 2018
0 references
31 December 2022
0 references
Masarykova univerzita
0 references
49°12'8.64"N, 16°36'28.44"E
0 references
49°11'55.68"N, 16°36'7.06"E
0 references
60200
0 references
Cílem projektu je optimalizace a preklinická profilace vybraných sloučenin s unikátní biologickou aktivitou s potenciálem vykázat terapeutickou účinnost při minimálních nežádoucích vedlejších účincích v oblasti onkologie a kardiologie. Náplní projektu bude mj. příprava širokého setu sloučenin a důkladné testování biologických a obzvláště farmakologických vlastností, včetně in vivo studií. Vzniklé duševní vlastnictví bude důsledně ošetřeno. Výsledky (TRL3)budou dopracovány s aplikačními firmami. a. (Czech)
0 references
The objective of the project is to optimise and preclinical profiling of selected compounds with unique biological activity with the potential to exhibit therapeutic efficacy in minimal side effects in oncology and cardiology. The project will include, inter alia, the preparation of a broad diet of compounds and a thorough testing of biological and particularly pharmacological properties, including in vivo studies. The resulting intellectual property will be thoroughly treated. The results (TRL3) will be finalised with application firmware. (English)
0 references
Identifiers
CZ.02.1.01/0.0/0.0/16_025/0007381
0 references